₹ 23.8434
NAV (Sep 17)
Investment Duration5 years
0
Total Investment0
Wealth Gained0
Total Corpus Created (₹)
With CAGR of 11.25 % in 5 years₹ 23.8434
NAV (Sep 17)
Last 1Y | 50.1% |
Last 3Y | 18.3% |
Last 5Y | NA |
Last 10Y | NA |
Since Inception | 16.6% |
6 Month CAGR | 25.2% |
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.
Expense Ratio | 0.21 |
Launched (0y ago) | 0.21 |
AUM in Crores | 798.6 |
ISIN | INF204KC1089 |
Lock-in | |
Benchmark | NIFTY Pharma Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | |
Standard Deviation | 16.3 |
Beta | 1 |
Sharpe Ratio | 0.8 |
YTM |
of
for
with step up of
Asset | Returns | Total Corpus | Gains | CAGR |
---|---|---|---|---|
Nippon India Nifty Pharma ETF (G) | 11,61,112 | 4,28,500 | 18.3% | |
EPF | 9,00,761 | 1,68,149 | 8.50% | |
Property | 8,67,662 | 1,35,050 | 7.00% | |
PPF | 8,69,819 | 1,37,207 | 7.10% | |
Bank FD | 8,46,471 | 1,13,859 | 6.00% | |
Gold | 8,46,471 | 1,13,859 | 6.00% | |
Savings Bank | 8,25,950 | 93,338 | 5.00% |
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
Sun Pharmaceutical Industries Ltd.
24.6%Dr. Reddy's Laboratories Ltd.
10.9%Cipla Ltd.
10.8%Divi's Laboratories Ltd.
8.3%Lupin Ltd.
6.1%Healthcare
99.9%Fund Name | Fund Size | |
---|---|---|
₹ 26,041 cr | ||
₹ 23,712 cr | ||
₹ 64,222 cr | ||
₹ 50,154 cr | ||
₹ 17,488 cr |
Nippon India Mutual Fund
Fund Name | Scripbox Opinion | Till Date CAGR | |
---|---|---|---|
5.901% | 6.864% | ||
6.568% | 8.931% | ||
17.933% | 21.08% | ||
21.978% | 13.718% | ||
14.951% | 8.07% |
Nippon India Nifty Pharma ETF (G) is a Equity Equity fund and has delivered an annualised return of 16.636% over a period of 3 years. The fund is managed by Nippon India Mutual Fund. The fund manager’s name is [object Object].
Nav of Nippon India Nifty Pharma ETF (G) as of 9/17/2024 is ₹23.84 with the total AUM as of 9/18/2024 is ₹798.6066. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Nifty Pharma ETF (G) was launched on 2021-07-02. The category risk of the fund is null.
The minimum SIP amount for Nippon India Nifty Pharma ETF (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
Nippon India Nifty Pharma ETF (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to NIFTY Pharma Total Return Index.
Nippon India Nifty Pharma ETF (G) is rated as a null fund in Equity and delivered 50.125% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Nifty Pharma ETF (G).
What is Nippon India Nifty Pharma ETF (G)?
How to invest in Nippon India Nifty Pharma ETF (G)?
You can invest in Nippon India Nifty Pharma ETF (G) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?
What is the minimum sip amount of Nippon India Nifty Pharma ETF (G)?
The minimum sip amount for Nippon India Nifty Pharma ETF (G) is ₹1000. You can invest in multiples of ₹5000.
Is Nippon India Nifty Pharma ETF (G) good to invest in?
As per Scripbox experts, Nippon India Nifty Pharma ETF (G) is a fund. You can investNippon India Nifty Pharma ETF (G) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.
What is the expense ratio of the Nippon India Nifty Pharma ETF (G)?
The expense ratio of the Nippon India Nifty Pharma ETF (G) is 0.21% for regular plan.